Primary Peritoneal Carcinoma Terminated Phase 1 Trials for Demcizumab (DB12734)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01952249A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant OvarianTreatment